Skip to content

Widely-used anti-alcoholism drug wakes up dormant HIV-infected cells

Does low-level HIV viral load raise the risk of disease progression and co-morbidities?

Andrea Antinori, presenting at EACS 2015. Photo by Liz Highleyman, hivandhepatitis.com

Post-treatment control of HIV appears rare, biomarkers may help predict viral rebound

Oestrogen may block HIV reactivation, hints at gender differences in viral reservoirs

Jonathan Karn at IAS 2015. Photo © Marcus Rose/IAS 2015.

Targets proliferate in HIV cure research

Dr Daniel Kuritzkes of Harvard Medical School gives keynote address: Progress and challenges in HIV cure research. Image by: Marcus Rose/IAS.

Young woman stays undetectable for twelve years off treatment after early HIV therapy

Dr Asier Saez-Cirion speaking at the Towards an HIV Cure symposium. Photo ©Steve Forrest/Workers' Photos/IAS.

New drug holds out promise of long-term control or even cure of HIV

One step further towards an HIV vaccine: and this one performed as expected

Transmitted HIV drug resistance is persistent but is not harming treatment responses in the UK